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Objective: Although anterior cruciate ligament (ACL) injury is a well-recognized risk factor for developing
knee post-traumatic osteoarthritis (PTOA), the process in the patellofemoral (PF) joint after ACL injury is
still under-researched. Our aim was to investigate the perfusion changes in PF subchondral bone marrow
in the rat ACL transection (ACLX) model of PTOA using dynamic contrast-enhanced magnetic resonance
imaging (DCE-MRI).
Design: Eighteen male Sprague Dawley rats were randomly separated into three groups (n ¼ 6 each
group): a normal control group and groups receiving ACLX and sham-surgery, respectively, in the right
knee. Perfusion parameters in the patellar and femoral subchondral bone marrows of all rats were
measured on DCE-MRI at 0, 4, 8, and 16 weeks after respective treatment. After the last MRI at week 16,
the rats were sacriﬁced and their right knees were harvested for histologic examination. In addition, to
observe the long-term histologic change in PF joints, 9 additional rats (n ¼ 3 in each group) were
included and sacriﬁced at week 32 for histologic examination.
Results: In the ACLX group vs the sham and control groups, the perfusion parameters were signiﬁcantly
changed in both patellar and femoral subchondral bone marrows at week 16. Histologic examination
revealed cartilage defects in ACLX rats at 32 weeks after surgery.
Conclusions: These data point to a possible functional relationship between subchondral bone marrow
perfusion abnormalities and cartilage breakdown in PTOA. Moreover, the perfusion parameters derived
from DCE-MRI can potentially serve as biomarkers of early OA.
© 2015 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.G.-S. Huang, Department of Radiology, Tri-Service General Hospital, National Defense Medical Center, No. 325, Sec. 2,
886-2-8792-7244; Fax: 886-2-8792-7245.
ternational. Published by Elsevier Ltd. All rights reserved.
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Post-traumatic arthritis (PTA) is a broad clinical term used to
describe articular degeneration after any kind of joint injury, such
as joint fractures, joint dislocations, ligament injuries, and cartilage
injuries1. The progression of PTAmay give rise to OA-like changes of
joint cartilage, referred to in the literature as post-traumatic oste-
oarthritis (PTOA)2. Anterior cruciate ligament (ACL) injury is by far
the most well known risk factor for developing PTOA. ACL insufﬁ-
ciency after the initial trauma causes chronic instability of the knee
and leads to OA, most recognizably in the tibiofemoral (TF) joint
where themajor stress develops. TF joint PTOA after an ACL tear has
been studied extensively; in contrast, the patellofemoral (PF) joint
PTOA associated with ACL injury is relatively under-researched.
However, this disease entity may be more common and impor-
tant than once thought3. In one prospective cohort study4, PF joint
OA was present in 16% of knees 15 years after the acute ACL injury.
PF joint PTOA is associated with increased functional deﬁcits (i.e.,
ﬂexion and extension) in ACL-deﬁcient patients4. PF joint OA is
even more prevalent (47%) than TF joint OA (31%) in patients
receiving autograft ACL reconstruction5,6. The long-term symptoms
and functional deﬁcits in these patients correlate with PF joint OA
severity but independent of the TF joint OA severity. In a broader
sense, regardless of the etiology, PF joint OA is an important source
of anterior knee pain7.
Dynamic contrast-enhanced magnetic resonance imaging (DCE-
MRI) provides a valuable noninvasive method to measure bone
marrow hemodynamics and derive several crucial perfusion pa-
rameters. A previous DCE-MRI study successfully demonstrated
signiﬁcant alteration of perfusion in a spontaneous TF joint OA
animalmodel8. A similar change can be anticipated in TF joints after
ACL injury based on the radiographic similarity of PTOA and pri-
mary OA. A preliminary study9 has already shown that the DCE-MRI
derived hemodynamic parameters change signiﬁcantly in the TF
joints of ACL-injured human subjects. Nonetheless, it would be
more intriguing to assess hemodynamic change in the more subtle,
late onset, yet equally important PF joint OA after ACL injury using
DCE-MRI, in the hope of developing hemodynamic change as an
early biomarker for PF joint PTOA. Therefore, the purpose of present
study is to use DCE-MRI to investigate the subchondral bone
marrow hemodynamics of the PF joints in rat model of knee OA
induced by ACL transection (ACLX) and to correlate DCE-MRI
ﬁndings with histologic examination.
Materials and methods
Ethics statement
The experiments were performed in accordance with the rec-
ommendations in the Guide for the Care and Use of Laboratory
Animals of the National Institutes of Health. The applied protocol
was approved by the Institutional Animal Care and Use Committee
of the National Defense Medical Center (Permit Number: IACUC-
06-103).
Animal preparation
Eighteen male Sprague Dawley rats aged 8 weeks and weighing
around 300 g were randomly separated into three groups (n¼ 6 for
each group): the normal control group without intervention, the
ACLX group where the right ACL was transected as previously
described10 while the left ACL was left intact, and the sham-control
group where the skin of the right knee was surgically wounded,
while the left knee was left intact. The rats were housed (two rats
per cage) in a sanitary ventilated room on a 12-h lightedark cyclewithin a temperature range of 21 ± 2C, with free access to tap
water and standard chow. The time when the rats received
respective treatment was designated as week 0. The right knees of
all rats were assessed using DCE-MRI at week 0, 4, 8, and 16. After
the last MRI, all the rats were sacriﬁced and their right knees har-
vested for histologic examination. In addition, to observe the long-
term histologic change of PF joint, 9 supplementary rats (n ¼ 3 in
each group) were included in the study, with DCE-MRI performed
at week 0, 4, 8, 16, and 32 and sacriﬁce performed at the end of the
MRI experiments for histologic examination.
DCE-MRI
The rats were ﬁrst anesthetized by inhalation of an iso-
ﬂuraneeoxygen mixture. A birdcage coil with an inner diameter of
72 mmwas used as the transmitter coil, and a separate quadrature
surface coil (Bruker, Ettlingen, Germany) was placed above both
knee joints to achieve maximum signal reception. The entire device
was placed in an Oxford Instruments (Bruker) 200/300 magnet
(4.7 T, 33 cm clear bore) equipped with an actively shielded Oxford
gradient coil (16 cm inner diameter, 18 G/cm, 200 ms rise time).
After three-plane tripilot imaging, 10 contiguous sagittal T2-
weighted images (T2WIs) were acquired for the purpose of later
slice positioning. In the subsequent imaging, four contiguous axial
imaging planes (slices) were placed nearly perpendicular to the
patella cartilage with the prior obtained right knee mid-sagittal
T2WIs as reference images [Fig. 1(a)].
DCE-MRI was performed as dynamic T1-weighted images
(T1WIs) using a fast gradient echo sequence with repetition
time ¼ 100 ms, echo time ¼ 3.5 ms, slice thickness ¼ 1 mm, matrix
size ¼ 128  128 (zero-ﬁlled to 256  256), in-plane
resolution ¼ 156  156 mm2, number of excitation ¼ 1, ﬂip
angle¼ 90, bandwidth¼ 37.879 kHz, and acquisition time¼ 6min
24 s. The rats received a bolus injection of gadolinium-diethylene
triamine pentaacetic acid (Gd-DTPA) (Magnevist; Bayer Health-
care Pharmaceuticals, Wayne, NJ, USA) via jugular vein at a dose of
0.2 mmol/kg during the 10th image acquisition. The temporal
resolution is 6.4 s.
Data analysis
The Gd-DTPA-enhanced kinetic signals were analyzed based on
the Brix two-compartment pharmacokinetic model11e13. Regions of
interest (ROIs) were drawn manually on the patella and femoral
subchondral bone marrows with reference to the ﬁrst DCE-MRI
image acquired at the middle level of the PF joint as shown in
Fig. 1(b). To minimize manual discrepancies in the positioning of
the ROIs, the ROIs were drawn by two image analysts well trained
in knee MRI (PHT, CYW) and their positions were conﬁrmed by an
experienced musculoskeletal radiologist (GSH). Results shown in
this study are the mean of two measurements. Mean signal in-
tensities of the ROIs at each imaging frame were calculated. Three
perfusion parameters were obtained from the timeeintensity curve
ﬁtting: amplitude (A), rate constant (kep), and elimination constant
(kel) as previously described13.
Histologic examination
All rats were sacriﬁced at the end of the MRI experiments (18
rats at week 16 and 9 rats at week 32). Right PF joints were
removed, ﬁxed in neutral formalin, and decalciﬁed in a rapid
decalciﬁer (Nihon Shiyaku Industries, Osaka, Japan). After decalci-
ﬁcation, the PF joint tissues were cut in half along the mid-axial
plane. Samples from each joint were parafﬁn-embedded, and cut
into 5-mm sections for hematoxylin and eosin (H&E) staining.
Fig. 1. DCE-MRI study. (a) Target slice for the perfusion measurement in the mid-sagittal plane and (b) ROIs selected for subsequent calculations of the perfusion parameters: ①
patellar bone marrow② femoral bone marrow. Moreover, curve ﬁtting of the normalized MR dynamic signal enhancement data of the patellar bone marrow in rats from the three
groups at 0 weeks (c), 16 weeks (d), and 32 weeks (e) are shown respectively. Compared to baseline values, inﬂow is altered and outﬂow reduced at 16 and 32 weeks after ACL
surgery.
Fig. 2. Histopathology of PF joint cartilage. (a) Subchondral bone marrow edema with
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The mean and the standard deviation (SD) of the derived
parametric perfusion data were ﬁrst calculated in each group. To
compare differences in the longitudinal effects of the parametric
perfusion indices among groups due to their dependence on
repeated measurements, the GEE (Generalized Estimating Equa-
tions) method's multiple linear regression was used to assess the
interaction of groups (ACLX, normal, and sham) with time (0, 4, 8,
and 16 weeks). SPSS v21.0 software (SPSS, Chicago, IL, USA) was
used to analyze the results of GEE with a ﬁrst-order autoregressive
correlation structure. The normality of the data and homogeneity of
variances were checked using the ShapiroeWilk test and Leven's
test, respectively. P-values < 0.05 were regarded as statistically
signiﬁcant.plasma accumulation (arrows) in the patella and femur was seen only in ACLX rats at
16 weeks after transection. The overlying cartilage was relatively intact. Original
magniﬁcation 200 (scale bars, 50 mm) (b) At 32 weeks after ACLX, matrix degener-
ation with irregular cartilage surface (arrow), and hypertrophic chondrocytes
(arrowhead), as well as subchondral bone marrow edema (curved arrows) were
recognized in ACLX rats, when compared to normal and sham-control rats. Original
magniﬁcation, 400 (scale bars, 25 mm).Results
DCE-MRI
Fig. 1(cee) shows representative contrast enhancement kinetic
curves of the patellar subchondral bone marrow in ACLX rats at
week 0 [Fig. 1(c)], week 16 [Fig. 1(d)] and week 32 [Fig. 1(e)]. As
shown in Fig. 1(c), peak signal enhancement was rapid (i.e., reached
within 1 min after contrast medium injection) and followed by a
gradual fade, indicating a rapid inﬂow and fairly slow washout of
the contrast medium in the patellar subchondral bone marrow. On
the other hand, perfusion MRI at week 16 resulted in a slightly
delayed time to peak enhancement with more gradual and slower
washout, indicating altered rates of contrast medium inﬂow and
washout rate in the subchondral bone marrow. A similar perfusion
pattern was observed in the PF joint of ALCX rats at week 32
[Fig. 1(e)].
The derived perfusion parameters, i.e., femoral A, kep, kel and
patellar A, kep, and kel values, were analyzed statistically
(Supplemental materials). For the femoral subchondral bone
marrow, the perfusion parameters (A, kep, kel) were initially similar
between groups (all P-values >0.05), not signiﬁcantly changed at
week 4, 8, and 16 compared to baseline values in the control and
sham groups (all P-values >0.05), and signiﬁcantly changed at week
16 (P-values <0.001, ¼0.012, and ¼0.013, respectively), but not at
week 4 and 8 (all P-values >0.05) in the ACLX group. The perfusion
parameters were similar between sham and control groups at all
time points. Similarly for the patellar subchondral bone marrow, A
and kel values were signiﬁcantly changed at week 16 (P ¼ 0.002,
and ¼0.024, respectively) but not at week 4 and 8 (all P-values
>0.05), and kep values were notably similar between the ACLX and
control groups (P-value ¼ 0.201) at week 16.Histologic examination
Fig. 2(a) shows representative H&E-stained sections of PF
joints in control, sham, and ACLX rats at week 16. In both the
patellar and femoral subchondral bone marrow, pale-staining
zones indicative of accumulated edema ﬂuid and plasma were
present in ACLX rats but not in control and sham rats. The PF joint
cartilage surface was intact in all three groups at week 16. Fig. 2(b)
shows histologic sections of PF joints at week 32. Notably at 32
weeks, the joint in ACLX rats showed matrix degeneration with
irregular cartilage surface, hypertrophic chondrocyte, as well as
subchondral bone marrow edema. The joint synovial membrane
showed mild synovitis with inﬂammatory inﬁltration of a few
lymphocytes.Discussion
In the rat ACLXmodel, our study demonstrates a perturbation of
perfusion in the PF subchondral bone marrow using DCE-MRI and
corresponding edematous change using histopathological
methods. The perfusion alteration in PF subchondral bone marrow
precedes the change in cartilagemorphology ﬁrst observed at week
32 after ACLX. These ﬁndings echo the previous reported results14,
which consistently show that perfusion abnormalities of sub-
chondral bone marrow developed in the early stage of OA.
In the present study, the elimination constant kel decreased
signiﬁcantly in both patellar and femoral subchondral bone
marrow in the ACLX rat. The reduced kel indicates prolonged
retention of contrast medium in the interstitium, which most likely
reﬂects impaired venous outﬂow. This is consistent with previous
work8,14e16 showing venous outﬂow obstruction as the primary
perfusion parameter change in human and animal OA studies. In
addition, the present study also revealed a signiﬁcant alteration of
the inﬂow-related parameters in the PF joint of the ACLX rat,
including elevated amplitude A and reduced rate constant kep. The
amplitude A is a relatively non-speciﬁc perfusion parameter, which
could be affected by several factors8. On the other hand, the rate
constant kep represents a ratio of permeability surface area product
per unit volume relative to the size of the interstitial space, and its
reduction can be readily attributed to decreased capillary endo-
thelial permeability or increased intraosseous pressure, both of
which limit the transfer of molecules from the capillary bed to
interstitial space8. Collectively, alterations in these perfusion pa-
rameters could infer that high intraosseous pressure, possibly
related to venous outﬂow obstruction, result in impaired vascular
inﬂow to the PF subchondral bone marrow in ACLX rats.
Despite their differing pathogenesis, PTOA and primary OA
share similar histologic and radiographic features. Nonetheless,
extrapolation of the “PTOA” condition in the ACLX model to that in
primary OA, or vice versa, should be treated with caution. Further
perfusion study in PTOA models as well as other OA models
involving injury to both TF and PF joints could provide more insight
into these disease entities.
Several limitations in the present study should be noted. First,
manual injection of contrast medium during DCE-MRI acquisition
may introduce variability in the lag time, rate and total dose of
contrast medium administered. Second, the ROI-based approach
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voxel wise comparison; therefore, subtle variation within the same
ROI may be masked. Third, the present study did not carry out
histology at each point to correlate histologic changewith DCE-MRI
change. In addition, the sample size used to determine the long-
term histologic change in the PF joint after ACLX was relatively
small. Fourth, the investigation of the perfusion change in TF joint
PTOA was not included in the present study, and a comprehensive
DCE-MRI study of TF joints after ACLX will be carried out in the
future.
In conclusion, the present study demonstrated an early perfu-
sion perturbation in the PF joint of rat after ACLX, which precede
the morphological destruction of the articular cartilage. These data
add to the growing body of evidence shedding light on a possible
functional relationship between subchondral bone marrow perfu-
sion abnormalities and cartilage breakdown. Moreover, the perfu-
sion parameters derived from DCE-MRI can potentially serve as
imaging biomarkers to enable early diagnosis of OA.
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